Jennifer L. Shenk

A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport

William R. Oliver, Jennifer L. Shenk, Mike R. Snaith et al. · Proceedings of the National Academy of Sciences · 2001 · 1K citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +15

Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662

Lisa M. Leesnitzer, Derek J. Parks, Randy K. Bledsoe et al. · Biochemistry · 2002 · 561 citations

Medicine, Medicinal Chemistry, Pharmacology +17

The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution

Stacey A. Jones, Linda B. Moore, Jennifer L. Shenk et al. · Molecular Endocrinology · 2000 · 559 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +16

The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding.

Jennifer L. F. Waterman, Jennifer L. Shenk, Thanos D. Halazonetis · The EMBO Journal · 1995 · 126 citations · Full text

Life Sciences, Genetics, Molecular Biology +9

p53 Represses Androgen-induced Transactivation of Prostate-specific Antigen by Disrupting hAR Amino- to Carboxyl-terminal Interaction

Jennifer L. Shenk, Christopher Fisher, Shaoyong Chen et al. · Journal of Biological Chemistry · 2001 · 103 citations · Full text

Life Sciences, Molecular Biology, Oncology +17